| Aug 24 |
Insider Selling: President and CEO Paul Bolno Sells 48,366 Shares of WAVE Life Sciences Ltd (WVE)
|
| Aug 12 |
Wave Life Sciences receives FDA rare disease designation for its duchenne muscular dystrophy treatment
|
| Aug 12 |
Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy
|
| Aug 11 |
Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
|
| Aug 10 |
Wave Life Sciences Ltd. (WVE) Q2 2024 Earnings Call Transcript
|
| Aug 10 |
Wave Life Sciences Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Aug 8 |
Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 8 |
Wave Life Sciences: Q2 Earnings Snapshot
|
| Aug 8 |
Wave Life Sciences GAAP EPS of -$0.25 misses by $0.07, revenue of $19.69M beats by $0.24M
|
| Aug 8 |
Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
|
